Affordable Access

Access to the full text

Icteric type hepatocellular carcinoma: Revisited 20 years later

Authors
  • Huang, Guan-Tarn1
  • Sheu, Jin-Chuan1
  • Lee, Hsuan-Shu1
  • Lai, Ming-Yang1
  • Wang, Teh-Hong1
  • Chen, Ding-Shinn2
  • 1 Department of Internal Medicine, Graduate Institute of Clinical Medicine National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei, Taiwan, 100, TW
  • 2 Hepatitis Research Center, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei, Taiwan, 100, TW
Type
Published Article
Journal
Journal of Gastroenterology
Publisher
Springer-Verlag
Publication Date
Jan 01, 1998
Volume
33
Issue
1
Pages
53–56
Identifiers
DOI: 10.1007/PL00009966
Source
Springer Nature
Keywords
License
Yellow

Abstract

Icteric type hepatocellular carcinoma is rare, and a poor prognosis has been demonstrated in the past. We performed this study to re-evaluate prognosis since the availability of modern diagnostic modalities. Of 3921 patients with hepatocellular carcinoma in our hospital, 9 patients who presented with tumor fragments in common bile duct and had a patent portal vein were submitted for analysis. Cholangiocarcinoma was suspected in 7 patients before the study was completed, and icteric type hepatocellular carcinoma was diagnosed in all 9 patients after serial studies that included serum alpha-fetoprotein levels, computed tomography, angiography, and histology. The prognosis was better in the 4 resectable patients (survival time 16, 31, 33, and 63 months, respectively), and was extremely poor for the 5 patients who received palliative treatment only (mean survival time, 4.5 months). Because of the apparently discrepant outcomes, this specific type of hepatocellular carcinoma should be kept in mind in areas where hepatocellular carcinomas are prevalent, and the suspected cases should be thoroughly investigated, because prognosis may be improved when resection is done at an earlier stage.

Report this publication

Statistics

Seen <100 times